Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I

Enzyme replacement therapy (ERT) can produce anti-drug antibody (ADA) responses that reduce efficacy or lead to hypersensitivity reactions. Six patients with severe mucopolysaccharidosis type I (MPS I/Hurler syndrome) who did not receive hematopoietic stem cell transplantation underwent an immunosup...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliani, Roberto, Vieira, Taiane Alves, Carvalho, Clarissa Gutierrez, Muñoz-Rojas, Maria-Veronica, Semyachkina, Alla N., Voinova, Victoria Y., Richards, Susan, Cox, Gerald F., Xue, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238455/
https://www.ncbi.nlm.nih.gov/pubmed/28119821
http://dx.doi.org/10.1016/j.ymgmr.2017.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238455/
https://www.ncbi.nlm.nih.gov/pubmed/28119821
http://dx.doi.org/10.1016/j.ymgmr.2017.01.004

Ejemplares similares